New Delhi: Even as Bharat Biotech is about to submit its phase 2 and 3 clinical trial result to India's drug regulator for emergency authorization for Covaxin for children, India's renowned experts have suggested that it's high time the schools should reopen.
Talking to ETV Bharat in an exclusive interview, public health expert and president of the Indian Association of Preventive and Social Medicine (IAPSM) Dr Suneela Garg said that school reopening is on the priority agenda of the government.
"One year of school closure is equivalent to two years of loss for a child in terms of development whether we talk of child to child development or overall development of the children. What children can get from going to school, they can never get at home," said Dr Garg.
She suggested that irrespective of vaccine availability, schools should reopen.
"We are amongst eight countries within the world where schools are closed," said Dr Garg.
Also read:WHO identifies counterfeit versions of Covishield in India
She reiterated that if the children are infected, it will be mild. "Children below 10 years of age or even 12 years have mild infection. However, children between 12-18 years of age are vulnerable to non-communicable diseases," said Dr Garg.
Referring to the serosurveys, Dr Garg pointed out that more than 60 per cent of the children were infected "and during this period they were not going to school. They were inside home, but they must have visited market places from where they got infected and generate antibodies."
She suggested that adults should be protected first.